• antiphospholipid syndrome: risk f actor for preeclampsia

    جزئیات بیشتر مقاله
    • تاریخ ارائه: 1401/03/31
    • تاریخ انتشار در تی پی بین: 1401/05/04
    • تعداد بازدید: 257
    • تعداد پرسش و پاسخ ها: 0
    • شماره تماس دبیرخانه رویداد: 09050265032

    antiphospholipid syndrome: risk f actor for preeclampsia

    antiphospholipid syndrome is the most frequently acquired risk factor for a treatable cause of recurrent abortion, stillbirth, preeclampsia, intrauterine death, premature birth, and fetal growth restriction. the purpose of this study was to review current literature about the antiphospholipid syndrome as a risk factor for preeclampsia.

    systematic literature searches using pre-specified terms were performed on pubmed, ovid embase, ovid medline, cochrane library, clinicaltrials.gov, and web of science from database inception dates to jun 2022. antiphospholipid syndrome, in relation to pregnancy, is characterized by the presence of antiphospholipid autoantibodies in association with repeated fetal loss and complications such as preeclampsia retarded fetal growth, or placental insufficiency.

سوال خود را در مورد این مقاله مطرح نمایید :

با انتخاب دکمه ثبت پرسش، موافقت خود را با قوانین انتشار محتوا در وبسایت تی پی بین اعلام می کنم